News

Abbott has received FDA approval for its Healon Duet Dual Pack OVD, which includes Healon and Healon EndoCoat OVDs in separate sterile trays.

The frequency with which retinectomy is performed has increased dramatically. Major management factors involve instruments, lensectomy and scleral buckling, the anterior retina, and complications.

The American Glaucoma Society (AGS) has chosen Thasarat S. Vajaranant, MD, to receive the Thom J. Zimmerman, MD, PhD Memorial Award, supported by Valeant Ophthalmics.

Ophthalmic Women Leaders (OWL) is now accepting nominations from OWL members for three annual awards, with a deadline of March 15.

Unoprostone isopropyl formulation (Rescula, Sucampo) makes alternative mechanism available for lowering IOP in open-angle glaucoma or ocular hypertension.

OptiMedica Corp. has received a patent for the Catalys Precision Laser System relating to the fundamental technology underlying laser cataract surgery.

Results from quality of life and vision surveys provide insight on patient-based subjective outcomes after bilateral implantation of presbyopia-correcting IOLs.

French physician was the chairman of the Department of Ophthalmology at Bordeaux University Medical School. He received numerous awards, and served on many editorial and other boards.

Take-Home MessageInvestors are shifting assets to passively managed vehicles. For many, exchange-traded funds (ETFs) have become the vehicle of choice. ETFs are investments that trade on exchanges, and are designed to mirror the performance of certain market indexes, so they tend to be passively managed.

We doctors should probably always think the best of our patients, honoring and respecting them. But that can be hard sometimes, because they are a bunch of liars. Does this seem a bit harsh to you? Well, a recent review of studies on patient veracity reveals some striking findings.

GALILEO is a sham-controlled pivotal trial investigating the efficacy and safety of aflibercept (Eylea, Bayer/Regeneron Pharmaceuticals) for the treatment of macular edema secondary to central retinal vein occlusion. Primary and secondary efficacy analyses after 6 months of routine monthly injections show consistent statistically significant treatment benefits.

This video animation demonstrates how the Argus II Retinal Prosthesis System (Second Sight Medical Products Inc.) operates.

This video testimonial features a male patient from Manchester, England, who received the Argus II Retinal Prosthesis System (Second Sight Medical Products Inc.) in 2009.

Optovue has received 510(k) clearance for the iCam Non-Mydriatic compact fundus camera, which produces 45° color fundus images of the eye as well as external ocular structures.

Regeneron Pharmaceuticals Inc. and Bayer HealthCare have initiated a new phase III trial to evaluate aflibercept (Eylea) injection in the treatment of DME in Russia and Asia.

The World Health Organization has approved the INN ”auriclosene” for NovaBay Pharmaceuticals Inc.’s lead Aganocide compound NVC-422 topical antimicrobial compound.

A glaucoma specialist discusses surgical treatment options in patients with painful blebs.

The Victus Femtosecond Laser Platform from Bausch + Lomb has received 510(k) clearance from the FDA for the creation of penetrating arcuate cuts/incisions in the cornea.

Optovue has received FDA 510(k) clearance for the Normative Database for the iVue spectral-domain optical coherence tomography (SD-OCT) system.